Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A thyroid gland adenoma composed of large cells with abundant granular eosinophilic cytoplasm and large nuclei with prominent nucleoli.
Biomarker and diagnostic research for thyroid gland oncocytic adenoma has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include other interventions. Research is sponsored by a mix of industry and academic institutions.
19 publications have been identified in PubMed for thyroid gland oncocytic adenoma. Research spans Case Report / Case Series (37%), Review / Meta-Analysis (26%), and Epidemiology / Natural History (26%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 37% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:43 AM UTC
Research summaries |
5 |
26% |
Disease patterns and progression | 5 | 26% |
Testing and diagnosis research | 1 | 5% |
Laboratory research | 1 | 5% |
Stefanovski DT (2026). [PMID: 41923565](https://pubmed.ncbi.nlm.nih.gov/41923565/). *Mol Imaging Radionucl Ther*. [Case Report / Case Series]
Ludányi KP (2026). [PMID: 41770233](https://pubmed.ncbi.nlm.nih.gov/41770233/). *Orv Hetil*. [Case Report / Case Series]
Finnegan EA (2026). [PMID: 41603381](https://pubmed.ncbi.nlm.nih.gov/41603381/). *J Clin Endocrinol Metab*. [Review / Meta-Analysis]
Balarezo Chalco SV (2026). [PMID: 42048648](https://pubmed.ncbi.nlm.nih.gov/42048648/). *Medwave*. [Case Report / Case Series]
Baloch Z (2025). [PMID: 39956101](https://pubmed.ncbi.nlm.nih.gov/39956101/). *Acta Cytol*. [Review / Meta-Analysis]
Pandya SS (2025). [PMID: 41133083](https://pubmed.ncbi.nlm.nih.gov/41133083/). *Cureus*. [Case Report / Case Series]
Peng H (2025). [PMID: 39259318](https://pubmed.ncbi.nlm.nih.gov/39259318/). *Eur Arch Otorhinolaryngol*. [Epidemiology / Natural History]
Lametti A (2025). [PMID: 40272265](https://pubmed.ncbi.nlm.nih.gov/40272265/). *Cancer Cytopathol*. [Review / Meta-Analysis]
Geetha SD (2025). [PMID: 39582472](https://pubmed.ncbi.nlm.nih.gov/39582472/). *Diagn Cytopathol*. [Basic Science / Preclinical]
Pilecki MJ (2025). [PMID: 40714458](https://pubmed.ncbi.nlm.nih.gov/40714458/). *J Surg Res*. [Epidemiology / Natural History]
AI-curated news mentioning thyroid gland oncocytic adenoma
Updated May 4, 2026
A study involving 260 patients with oncocytic thyroid cancer reveals insights into recurrence rates and survival based on initial treatment responses. This single-institution experience contributes valuable data to the understanding of this rare cancer type.